Insights

More Articles Back to Article

CureVac secures $85M loan to build COVID-19 vaccine plant

Germany's CureVac has secured an $85 million loan from the European Investment Bank to expedite the completion of a fourth manufacturing facility for an mRNA-based COVID-19 vaccine under development. The company is preparing an initial public offering in the US this month. Reuters (7/6)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!